In Silico and In Vitro Studies of 4-Hydroxycoumarin-Based Heterocyclic Enamines as Potential Anti-Tumor Agents

Molecules. 2023 Aug 2;28(15):5828. doi: 10.3390/molecules28155828.

Abstract

The present study reports the one-step synthesis of several 3-formyl-4-hydroxycouramin-derived enamines (4a-4i) in good yields (65-94%). The characterization of the synthesized compounds was carried out via advanced analytical and spectroscopic techniques, such as melting point, electron impact mass spectrometry (EI-MS), 1H-NMR, 13C-NMR, elemental analysis, FTIR, and UV-Visible spectroscopy. The reaction conditions were optimized, and the maximum yield was obtained at 3-4 h of reflux of the reactants, using 2-butanol as a solvent. The potato disc tumor assay was used to assess Agrobacterium tumefaciens-induced tumors to evaluate the anti-tumor activities of compounds (4a-4i), using Vinblastine as a standard drug. The compound 4g showed the lowest IC50 value (1.12 ± 0.2), which is even better than standard Vinblastine (IC50 7.5 ± 0.6). For further insight into their drug actions, an in silico docking of the compounds was also carried out against the CDK-8 protein. The binding energy values of compounds were found to agree with the experimental results. The compounds 4g and 4h showed the best affinities toward protein, with a binding energy value of -6.8 kcal/mol.

Keywords: anti-tumor; coumarin; enamines; hydroxycoumarin.

MeSH terms

  • 4-Hydroxycoumarins*
  • Antineoplastic Agents* / chemistry
  • Molecular Docking Simulation
  • Molecular Structure
  • Structure-Activity Relationship
  • Vinblastine

Substances

  • Vinblastine
  • Antineoplastic Agents
  • 4-Hydroxycoumarins

Grants and funding

Funding in the C.L. lab was provided by the Fundamental Research Funds for the Central Universities (2232021G-04), Shanghai Science and Technology Committee (19ZR1471100). The authors are also thankful for the online utilization of computational resources at C.L. lab, Donghua University, China.